课题基金 / 基金详情

Research Project 2

Research Project 2
研究项目2
批准号:
10738443
负责人:
Juliet Iwelunmor
金额:
$23.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-19 至 2028-08-31
关键词:
AdultAfricaAfricanAutomobile DrivingBirthCancer ControlCaringCessation of lifeChildChinaChronic Hepatitis BClinicClinicalCommunitiesCommunity DevelopmentsCommunity Health AidesConsolidated Framework for Implementation ResearchCountryCreativenessDataDecentralizationDoseElementsEngineeringEquityEvaluationFaceGuidelinesHBV Liver CancerHealth ServicesHepatitisHepatitis BHepatitis B InfectionHepatitis B TransmissionHepatitis B VaccinesHepatitis B VirusHomeHospitalsHourHybridsImmunityImmunizationIndividualInfantInterventionLiver diseasesMalignant neoplasm of liverMeasuresMedicineMothersNational Cancer InstituteNewborn InfantNigeriaNigerianPersonsPoliciesPopulationPregnant WomenPreventionPrimary carcinoma of the liver cellsPrintingProtocols documentationRandomized, Controlled TrialsRecommendationRecordsRequest for ApplicationsResearchResearch MethodologyResearch Project GrantsRiskServicesSiteTimeTrainingUnited States National Academy of SciencesUnited States National Institutes of HealthVaccinationVaccinesVertical Disease Transmissionchronic infectioncohortcommunity cliniccommunity engagementconcept mappingcrowdsourcingeffectiveness evaluationeffectiveness/implementation designemerging adultimplementation outcomesimplementation processimplementation researchimplementation scienceimplementation strategyinfant infectioninnovationlow and middle-income countriesmathematical modelneonatal infectionpost implementationpreferenceprimary outcomesecondary outcomestandard caretesting uptakeuptakevaccine acceptancevaccine delivery

项目摘要

项目成果

Juliet Iwelunmor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Every hour, over 150 people die of hepatitis-related liver diseases in African countries like Nigeria, including hepatocellular carcinoma (HCC) and other liver cancers. Much of this death is attributable to the hepatitis B virus (HBV). A hepatitis B birth dose (HepB-BD) vaccine initiated within 24 hours of birth, followed by three additional pentavalent HBV vaccines (at six, 10, and 14 weeks after birth), provide durable immunity, substantially decreasing the risk of HBV and liver cancer. Nigerian national guidelines recommend HepB-BD vaccination for all newborns and provides them for free as part of the national immunization protocol, yet uptake is suboptimal, highlighting the need for implementation science research to develop locally relevant strategies to increase HepB-BD vaccine uptake. We propose a crowdsourcing approach to enhance timely coverage of HepB-BD vaccination in Nigeria. Crowdsourcing has a group of people solve all or part of a problem, then implement selected solutions. Our team used crowdsourcing to develop messages promoting HBV testing uptake, inform global hepatitis guidelines, and enhance hepatitis community engagement in low and middle-income countries (LMICs). Our study will focus on developing and implementing strategies to increase HepB-BD vaccination at community clinics, home births, and other sites outside of hospitals where most pregnant women receive care. The Consolidated Framework for Implementation Science Research (CFIR) and concept mapping will guide our evaluation of factors influencing uptake and sustainment. Our specific aims are: 1) To determine pregnant women's preferences on HepB-BD vaccination using community-engaged crowdsourcing research and finalize an implementation strategy to increase HepB-BD vaccination; 2) To determine the effectiveness of a finalized crowdsourced HepB-BD vaccination intervention among a cohort of pregnant women using a community-based clinic-level cluster RCT. Trained community health workers will implement the final intervention in a cluster randomized control trial of the crowdsourced intervention versus standard care (i.e. printed guidelines) among a cohort of 720 dyads (pregnant women and newborns) at 36 community-based clinics (n=1440); and 3) To use mixed methods research to determine multi-level factors that influence uptake and sustainment of crowdsourced HepB-BD vaccination over time. Primary outcome is HepB-BD vaccination ascertained by clinic records. Secondary outcome is service sustainment at the community-based clinic level, defined here as the percent sustainment of core elements of the final campaign measured 12 months after the trial, with sustained benefits and capacity for implementation at each community-based clinic. Our study is responsive to the U54 request for applications for global implementation science for equitable cancer control and and the strategic priorities of the National Cancer Institute. This study will provide a unique opportunity to expand HBV vaccine coverage, driving equitable implementation science research in settings traditionally under-represented in implementation science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Engagement Core
  • 批准号:
    10738440
  • 项目类别:
  • 资助金额:
    $19.84万
  • 财政年份:
    2023
  • 负责人:
    Juliet Iwelunmor
  • 依托单位:
Research Project 1
  • 批准号:
    10738442
  • 项目类别:
  • 资助金额:
    $25.55万
  • 财政年份:
    2023
  • 负责人:
    Juliet Iwelunmor
  • 依托单位:
Research and Capacity Building Core
  • 批准号:
    10738441
  • 项目类别:
  • 资助金额:
    $35.83万
  • 财政年份:
    2023
  • 负责人:
    Juliet Iwelunmor
  • 依托单位:
NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations
  • 批准号:
    10686222
  • 项目类别:
  • 资助金额:
    $0.81万
  • 财政年份:
    2022
  • 负责人:
    Juliet Iwelunmor
  • 依托单位:
海外基金